Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal
Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2610 in its research report dated June 01, 2026.
Neutral Indegene; target of Rs 552: Motilal Oswal
Motilal Oswal recommended Neutral rating on Indegene with a target price of Rs 552 in its research report dated May 02, 2026.
Nifty recovers 200 points from intra-day lows; IT continues outperformance | Closing Bell
Indian equities erased all the intraday losses with Nifty back above 23,500. TCS, Infosys, HCL Tech, Tech Mahindra, Trent are among top gainers on the Nifty, while losers are NTPC, Power Grid Corp, Cipla, Dr Reddy's Labs and L&T. Among sectors IT index up 4%, while auto, metal, Consumer Durables, realty up 0.5% each. However, pharma, healthcare, power, media, energy down 0.5-1%. Nifty Midcap and Smallcap indices down marginally. Catch Lovish Darad in conversation with Market Experts.
Sensex Today | Stock Market Live: GIFT Nifty hints a muted start; US, Asian markets fall
Sensex Today | Stock Market LIVE Updates: Wall Street stocks pulled back from record highs on Wednesday as flaring tensions in the Middle East and rising crude prices stoked inflation jitters and convinced investors to take some profits. The Dow Jones Industrial Average fell 620.72 points, or 1.21%, to 50,687.07, the S&P 500 lost 56.06 points, or 0.74%, to 7,553.72 and the Nasdaq Composite lost 239.92 points, or 0.89%, to 26,853.98.
Taking Stock: Sensex, Nifty end flat ahead of RBI policy; consumer durables, capital goods shine
More than 120 stocks touched their 52-week high on the BSE, including Cemindia Projects, Nippon Life India Asset Management, Jindal Saw, HFCL, Syrma SGS, Laurus Labs, Polycab, Vodafone Idea, Federal Bank, IFCI, JK Bank, Welspun Corp, RBL Bank, among others.
Taking Stock: Market recovers but Nifty ends below 24,000; Sensex falls 583 pts
More than 100 stocks touched their 52-week high on the BSE, including Himadri Speciality, HFCL, Sai Life Sciences, Coal India, Hitachi Energy, Navin Fluorine, ONGC, Apar Industries, MCX India, Lloyds Metals, Chennai Petro, among others.
Buy Five Star Business Finance; target of Rs 600: Motilal Oswal
Motilal Oswal is bullish on Five Star Business Finance has recommended buy rating on the stock with a target price of Rs 600 in its research report dated April 29, 2026.
Buy Granules India; target of Rs 820: Motilal Oswal
Motilal Oswal is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 820 in its research report dated April 29, 2026.
Live: Nifty logs second weekly loss; rupee rebounds 80 paise | Closing Bell
Indian equities traded lower on Friday afternoon as weakness in metal and information technology stocks outweighed gains in select financial, healthcare and consumer names. At 2:18 pm, the Sensex was down 299.98 points or 0.40 percent at 74,060.03, while the Nifty slipped 110.15 points or 0.47 percent to 23,306.40. Market breadth remained weak, with 2,070 stocks declining against 1,720 advances. The Nifty Metal index dropped nearly 2 percent and Nifty IT fell over 1 percent, while broader markets also underperformed. However, the Nifty Media index surged more than 2 percent and realty stocks traded higher, offering some support. Catch Lovish Darad in conversation with Market Experts.
Buy Mankind Pharma; target of Rs 2640: Motilal Oswal
Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2640 in its research report dated April 29, 2026.
Buy Piramal Pharma; target of Rs 190: Motilal Oswal
Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 190 in its research report dated April 29, 2026.
Buy Star Health; target of Rs 640: Motilal Oswal
Motilal Oswal is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 640 in its research report dated April 29, 2026.